Abpro Bio Co., Ltd. (KOSDAQ: 195990)

Abpro Bio Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	24,992	18,856	16,951	53,961	26,840	14,957
Short-Term Investments	6,308	944.31	796.04	430.25	-	10.1
Trading Asset Securities	-	68.36	4,087	-	4,045	-
Cash & Short-Term Investments	31,300	19,869	21,834	54,391	30,885	14,967
Cash Growth	64.10%	-9.00%	-59.86%	76.11%	106.35%	45.52%
Accounts Receivable	9,757	3,994	3,226	2,781	4,085	4,164
Other Receivables	975.15	1,039	325	1,412	625.75	6,266
Receivables	17,448	7,868	4,451	4,193	4,837	10,621
Inventory	15,068	16,432	18,610	15,189	12,664	16,886
Prepaid Expenses	-	37.43	40.62	520.3	564.26	1,002
Other Current Assets	1,509	598.36	857.22	7,610	8,858	37,949
Total Current Assets	65,324	44,804	45,793	81,903	57,808	81,426
Property, Plant & Equipment	11,881	22,579	23,099	24,170	39,552	49,738
Long-Term Investments	56,602	56,413	79,772	57,308	61,656	52,667
Goodwill	16,918	8,004	-	-	-	6,873
Other Intangible Assets	2,162	3,482	2,388	3,621	500.14	5,242
Long-Term Accounts Receivable	-	252	-	-	-	-
Long-Term Deferred Tax Assets	392.03	125.75	-	-	-	3,521
Other Long-Term Assets	5,473	6,450	5,563	848.94	6,256	3,020
Total Assets	158,752	142,110	156,646	167,884	166,028	202,871
Accounts Payable	7,188	2,127	1,559	2,911	2,227	1,346
Accrued Expenses	694.06	755.34	733.9	478.75	1,682	2,067
Short-Term Debt	8,570	9,249	10,196	21,013	2,495	26,886
Current Portion of Long-Term Debt	196.56	333.16	-	-	-	-
Current Portion of Leases	496.36	367.48	303.02	214.43	195.64	174.48
Current Income Taxes Payable	23.04	7.35	-	-	3.21	-
Other Current Liabilities	5,272	5,085	3,217	5,143	8,229	33,793
Total Current Liabilities	22,440	17,925	16,009	29,760	14,831	64,265
Long-Term Debt	5,351	1,294	-	-	8,463	14,082
Long-Term Leases	617.26	550.76	441.24	582.9	241.35	304.85
Long-Term Deferred Tax Liabilities	-	-	-	-	-	1,071
Other Long-Term Liabilities	20	-0	0	0	4,294	3,960
Total Liabilities	28,427	19,769	16,450	30,343	27,830	83,683
Common Stock	142,345	142,345	136,845	130,102	125,735	88,382
Additional Paid-In Capital	89,116	89,116	87,288	85,635	83,596	39,046
Retained Earnings	-106,374	-112,935	-87,193	-79,070	-68,918	-9,920
Treasury Stock	-2.9	-2.9	-2.9	-2.9	-2.9	-2.9
Comprehensive Income & Other	5,240	3,817	3,259	876.8	-1,310	-59.71
Total Common Equity	130,325	122,340	140,196	137,541	139,100	117,445
Minority Interest	-	-	-	-	-902.41	1,743
Shareholders' Equity	130,325	122,340	140,196	137,541	138,198	119,188
Total Liabilities & Equity	158,752	142,110	156,646	167,884	166,028	202,871
Total Debt	15,231	11,794	10,940	21,811	11,395	41,447
Net Cash (Debt)	16,069	8,075	10,893	32,581	19,491	-26,480
Net Cash Growth	89.65%	-25.88%	-66.56%	67.16%	-	-
Net Cash Per Share	56.45	29.02	40.60	120.84	90.96	-202.83
Filing Date Shares Outstanding	284.69	284.69	273.69	260.2	251.47	176.76
Total Common Shares Outstanding	284.69	284.69	273.69	260.2	251.47	176.76
Working Capital	42,884	26,879	29,783	52,143	42,976	17,160
Book Value Per Share	457.78	429.74	512.25	528.59	553.15	664.42
Tangible Book Value	111,245	110,854	137,808	133,920	138,600	105,330
Tangible Book Value Per Share	390.76	389.39	503.52	514.68	551.17	595.89
Land	3,174	10,000	10,000	10,000	11,475	15,319
Buildings	6,845	18,480	18,494	18,607	26,565	26,705
Machinery	6,736	6,996	7,352	7,218	17,595	18,192
Construction In Progress	1,050	500	-	145.23	148	-

Source: S&P Capital IQ. Standard template. Financial Sources.